Table 1

Timing of consultations and their phases in minutes

Patient

Opening

Examination

Standard Gamble

Risk Assessment

Decision Making

Closure

Total

Guidelines

1

4.2

10.2

n/a

3.5

1.2

0.9

20.0

2

3.0

16.2

n/a

3.5

1.4

1.6

25.7

3

2.6

10.7

n/a

2.9

1.2

1.0

18.4

4

4.6

14.5

n/a

4.0

3.4

0.8

27.3

5

3.4

9.3

n/a

5.2

10.1

0.3

28.3

6

2.0

10.9

n/a

3.5

1.6

0.8

18.8

7

6.9

9.4

n/a

1.1

1.8

0.4

19.6

8

3.1

11.4

n/a

2.9

5.3

1.7

24.4

9

3.3

14.0

n/a

3.4

0.7

0.6

22.0

10

2.4

8.4

n/a

4.7

1.8

2.9

20.2

Implicit

1

2.3

18.2

n/a

12.6

6.8

4.5

44.4

2

3.9

14.0

n/a

8.4

3.0

2.3

31.6

3

0.7

12.8

n/a

9.8

12.1

5.6

41.0

4

1.0

14.3

n/a

7.7

4.4

7.0

34.4

5

6.8

21.5

n/a

5.9

5.2

7.9

47.3

6

2.4

3.9

n/a

5.7

0.9

3.5

16.4

7

2.5

3.2

n/a

5.6

1.9

2.2

15.4

8

1.4

2.7

n/a

7.4

1.9

2.0

15.4

9

0.8

13.0

n/a

9.7

3.5

1.8

28.5

10

3.3

9.4

n/a

7.3

7.3

3.6

30.9

11

1.6

8.3

n/a

7.3

5.4

2.3

24.9

Explicit

1

2.5

1.4

21.9

9.7

2.4

5.0

42.9

2

1.1

10.4

14.3

8.9

8.1

8.8

51.6

3

1.6

6.6

13.2

6.5

7.6

2.5

38.0

4

2.0

7.0

19.0

5.1

7.7

2.4

43.2

5

3.1

14.1

20.9

3.4

9.1

5.6

56.2

6

2.7

9.4

25.9

4.6

7.5

9.1

59.2

7

4.6

10.6

16.0

5.2

6.9

1.7

45.0

8

1.3

9.6

10.5

3.1

2.0

3.1

29.6

Footnote: cases in each condition are in the order they occurred in the trial

Kaner et al. BMC Medical Informatics and Decision Making 2007 7:2   doi:10.1186/1472-6947-7-2